Cough & Lung Acoustic Endpoints for Clinical Trials

The RESP® Biosensor

FDA 510(k) Class II | CE Mark | HIPAA Compliant

RESP Cough Monitoring System

RESP® Biosensor Overview

The RESP® Biosensor is a next generation digital health technology developed to collect greater respiratory insights in clinical trials and research studies.

  • Patient-Friendly: Wireless, discreet form factor that respects patient comfort in daily life
  • Multi-Parameter: Comprehensive respiratory and physiological measurements 
  • Validated Reporting: Automated or manual (human) analysis of cough and lung sounds
RESP Biosensor for Clinical Trials

Measures

A robust combination of multi-modal data alongside patient reported outcomes (PROs)

Cough Monitoring
          • Cough Frequency (24-hour)
          • Cough Sound Intensity & Bouts
          • Wheeze, Rhonchi, Crackles
          • Breathing Patterns*
          • Respiratory Rate*
          • Heart Rate & Heart Rate Variability*
          • Orientation (e.g. Supine or Upright)*
          • Sleep/Wake*
          • Activity Levels*

*Measurement not FDA cleared but may be collected in clinical trials

Clients & Partners

Metrics-at-a-Glance

1.5M

Lung Sounds Captured

50M

Breaths Captured

5

Continents

34

Countries

36

Languages

245

Sites

Why Measure Cough & Lung Sounds in Your Study?

From primary, exploratory endpoints to sub-studies, RESP® can add value to your clinical program by:

  • Increasing evidence and insight into how patients feel and function
  • Reducing reliance on PROs to demonstrate treatment effectiveness with another objective lens
  • Differentiating your asset in an increasingly competitive market 
  • Uncovering signals that may point to new or expanded indications

Digital Endpoints for Multiple Indications

Unlock insight across therapeutic areas to complement patient-reported outcomes and strengthen evidence

Cough Wheeze Crackles Rhonchi Respiratory Rate* Heart Rate* Activity*
Chronic Cough
Pulmonary Fibrosis
Bronchiectasis
COPD
Asthma
Infectious Diseases
Lung Cancer
Congestive Heart Failure
  • Chronic Cough
  • IPF
  • Bronchitis
  • COPD
  • Asthma
  • RSV
  • Covid-19
  • Heart Failure

*Measurement not FDA cleared but may be collected in clinical trials

Features & Specifications

    • Wireless and discreet
    • Passive and continuous
    • Lightweight (100g)
    • Data transfer to cloud
    • 24+ hour battery life
    • Water resistant
    • Adhered to chest via 3M Tegaderm dressing
    • Patient-privacy preserving (HIPAA compliant)
    • Flexible reporting including automated or human analysis of cough and lung sounds
    • Verifications: FDA 510(k) Class II and CE Mark

 

Cough Monitor - RESP

Publications

Stepwise Validation Program

Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough

Poster Presentation, American Thoracic Society, 2025

Objective Cough Monitoring
Objective Cough Monitoring Detects More Patients with Cough Than Patient Self-Reporting

Poster Presentation, American Cough Conference, 2023

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Explore using the RESP® Biosensor in your next study